LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 228 filers reported holding LOXO ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,206,143 | -17.5% | 8,611 | +0.7% | 0.02% | -7.7% |
| Q3 2018 | $1,461,280 | -99.9% | 8,554 | 0.0% | 0.03% | +8.3% |
| Q2 2018 | $1,483,948,000 | +82.8% | 8,554 | +21.6% | 0.02% | +118.2% |
| Q1 2018 | $811,859,000 | +131909.6% | 7,037 | -3.7% | 0.01% | +37.5% |
| Q4 2017 | $615,000 | -56.6% | 7,311 | -52.5% | 0.01% | -11.1% |
| Q3 2017 | $1,417,000 | +29.4% | 15,382 | +12.6% | 0.01% | +12.5% |
| Q2 2017 | $1,095,000 | +146.6% | 13,656 | +29.3% | 0.01% | +166.7% |
| Q1 2017 | $444,000 | +31.0% | 10,559 | 0.0% | 0.00% | +50.0% |
| Q4 2016 | $339,000 | -10.3% | 10,559 | -26.8% | 0.00% | -33.3% |
| Q3 2016 | $378,000 | +54.3% | 14,422 | +36.6% | 0.00% | +50.0% |
| Q2 2016 | $245,000 | +28.3% | 10,559 | +51.5% | 0.00% | +100.0% |
| Q1 2016 | $191,000 | -3.5% | 6,971 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $198,000 | – | 6,971 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,438,920 | $289,488,000 | 57.19% |
| DAFNA Capital Management LLC | 296,000 | $24,917,000 | 13.42% |
| Casdin Capital, LLC | 360,000 | $30,305,000 | 7.38% |
| Opaleye Management Inc. | 176,300 | $14,841,000 | 4.75% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 574,495 | $48,361,000 | 1.84% |
| SECTORAL ASSET MANAGEMENT INC | 152,185 | $12,811,000 | 1.60% |
| AWM Investment Company, Inc. | 85,000 | $7,155,000 | 1.39% |
| Eventide Asset Management | 285,000 | $23,991,000 | 1.25% |
| Rock Springs Capital Management LP | 310,000 | $26,096,000 | 1.18% |
| Crawford Lake Capital Management, LLC | 53,420 | $4,497,000 | 1.06% |